Tenaya Therapeutics, Inc.
SEC CIK 1858848 · TNYA · last insider filing 2026-05-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Williams R Sanders | Director | filed 2021 - 2026 |
| Walsh Jeffrey T. | Director | filed 2021 - 2026 |
| Parschauer Karah Herdman | Director | filed 2021 - 2026 |
| Lee June | Director | filed 2021 - 2026 |
| Stehman-Breen Catherine | Director | filed 2021 - 2026 |
| Srivastava Deepak | Director | filed 2021 - 2026 |
| Burroughs Amy L. | Director | filed 2022 - 2026 |
| Ali Faraz | Director · Chief Executive Officer | filed 2021 - 2026 |
| Goeddel David V | Director | filed 2021 - 2025 |
| Chen JIN-Long | Director | filed 2021 - 2023 |
| Casdin Capital, LLC | Director | filed 2021 - 2022 |
| Casdin Eli | Director | filed 2021 - 2022 |
| Kang Jeenjoo | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tingley Whittemore | Chief Medical Officer | filed 2021 - 2026 |
| Higa Tomohiro | SVP, Finance | filed 2025 - 2026 |
| Saito Chihiro | SVP, Accounting and Fin. Ops. | filed 2024 - 2024 |
| Hoey Timothy | Chief Scientific Officer | filed 2021 - 2024 |
| Patterson Leone D | Chief Fin. and Bus. Officer | filed 2021 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.